The University of Tennessee Health Science Center - Department of Comparative Medicine

The Drug Enforcement Administration (DEA) changes ketamine to Schedule 3. Ketamine hydrochloride (ketaset, ketalar, vetalar), alone or in combination with other drugs, is widely used in laboratory animals as an anesthetic. It’s popularity is base on a wide margin of safety, compatibility with other drugs and ease of use. The Drug Enforcement Administration (DEA) announced on July 13th, that ketamine will become a controlled substance (Schedule 3) effective August 12, 1999. All investigators who use ketamine and wish to continue using ketamine or other controlled substances must have a Federal DEA registration (research or practitioner) in order to purchase and use ketamine or other controlled substances. The University of Tennessee, Memphis controlled substance policy requires investigators to have a DEA registration (either clinical or research) and to comply with record keeping and storage requirements. Please note the Department of Comparative Medicine will no longer be able to dispense ketamine or ketamine mixtures without a DEA registration number. Any ketamine or ketamine containing products (or other controlled substances) that you have in your laboratory must be secured with lock and key. Inventory must be recorded and accounted for each ml of ketamine used.

NOTE: This is a federal requirement, as well as a request of the University's controlled substance policy. All future purchases of ketamine and ketamine containing products or other controlled substance can be made through or with the approval of UT Bowl Hospital Pharmacy.
 

Webmaster Last Updated: 5/31/00 Disclaimer, Internet Technology Policy, Network Publishing Guidelines, UT Memphis Home Page The University of Tennessee is an EEO/AA/Title VI/Title IX/Section 504/ADA/ADEA institution.